Several oncolytic viruses for the treatment of urological cancers have been investigated in clinical trials. Delwar et al. summarize the challenges encountered to the success of these agents and discuss strategies to improve effectiveness and safety.
- Zahid Delwar
- Kaixin Zhang
- William Jia